Developer:
MedLearning2017
Google Play Developer
MedLearning2017
App Count: 32
Developer URL: play.google.com/store/apps/developer?id=MedLearning2017
All apps from developer ID: MedLearning2017
Individualizing Diabetes Care
MedLearning2017
Myeloma BsAb iAR
MedLearning2017
Medical Management of Melanoma
MedLearning2017
Understanding RVO
MedLearning2017
Non-Small-Cell Lung Cancer
MedLearning2017
Biologics in CRSwNP
MedLearning2017
Familial Hypercholesterolemia
MedLearning2017
DR & PRP Therapy
MedLearning2017
Shaping the Future of NMSC
MedLearning2017
Targeting Type 2 Inflammation
MedLearning2017
| App | Installs | Rating | |
|---|---|---|---|
| 1 | Individualizing Diabetes Care | 10 | - |
| 2 | Myeloma BsAb iAR | 4.00 | - |
| 3 | Medical Management of Melanoma | 14 | - |
| 4 | Understanding RVO | 24 | - |
| 5 | Non-Small-Cell Lung Cancer | 63 | - |
| 6 | Biologics in CRSwNP | 3.00 | - |
| 7 | Familial Hypercholesterolemia | 11 | - |
| 8 | DR & PRP Therapy | 64 | - |
| 9 | Shaping the Future of NMSC | 4.00 | - |
| 10 | Targeting Type 2 Inflammation | 3.00 | - |
Apps Matched by Domain (Possibly Related)
There are 55 apps that are possibly related via the developer's domain (medlearninggroup.com). These may be developer apps on other App Stores or App Store Developers. For social networks like FB/TikTok/X there may be unrelated apps using their social pages as their official domain.
Familial Hypercholesterolemia
MedLearning2017
Treating SR-cGVHD
MedLearning2017
Understanding Rett Syndrome
MedLearning2017
AMD & Anti-VEGF Therapy
MedLearning2017
Targeted Asthma Therapy
MedLearning2017
Targeting Type 2 Inflammation
MedLearning2017
SGLT2 & GLP-1 in Diabetes
MedLearning2017
Myeloma BsAb iAR
MedLearning2017
Anti-VEGF Advances in Retina
MedLearning2017
Moderate to Severe Asthma AR
MedLearning2017
| App | Installs | Rating | |
|---|---|---|---|
| 1 | Familial Hypercholesterolemia | 11 | - |
| 2 | Treating SR-cGVHD | 3.00 | - |
| 3 | Understanding Rett Syndrome | 15 | - |
| 4 | AMD & Anti-VEGF Therapy | 39 | - |
| 5 | Targeted Asthma Therapy | 8.00 | - |
| 6 | Targeting Type 2 Inflammation | 3.00 | - |
| 7 | SGLT2 & GLP-1 in Diabetes | 38 | - |
| 8 | Myeloma BsAb iAR | 4.00 | - |
| 9 | Anti-VEGF Advances in Retina | 4.00 | - |
| 10 | Moderate to Severe Asthma AR | 81 | - |
Anti-VEGF’s in DR, AMD & RVO
Med Learning Group
Myeloma BsAb iAR
Med Learning Group
Anti-VEGF Advances in Retina
Med Learning Group
Multiple Myeloma Management
Med Learning Group
Managing Atopic Dermatitis
Med Learning Group
Biologics in CRSwNP
Med Learning Group
Covid Frontline AR
Med Learning Group
Medical Management of Melanoma
Med Learning Group
Antiarrhythmics for Afib
Med Learning Group
Understanding Type 1 Diabetes
Med Learning Group